MDD Interview with Onur Okan Demirci

Dr Onur Okan Demirci has worked as a Specialist Psychiatrist in the Psychiatry Department in Tatvan State Hospital, Turkey, and is currently setting up a private practice. He described his typical case load within the state hospital allowing him to see each patient for only a few minutes per visit. With a population of nearly 80 million in Turkey, and few psychiatrists, there is enormous pressure on the system. Onur described his role as mainly one of prescribing – time is simply not available to offer extended therapy sessions.

What are your biggest challenges when treating patients with MDD?

Patients don’t want to take pills – they want therapy, they want to talk through their problems. Once patients do start taking medication, they often don’t take it correctly or for long enough. They ‘quit’. I have seen patients struggle with depression for years.

What fraction of your patients with MDD have residual symptoms, when they have responded to antidepressant treatment?

Most patients do not get back to their ‘usual self’.

How do you treat your patients with MDD?

In my private practice, in addition to drugs, patients are offered group therapy, eye movement desensitization and reprocessing (EMDR) and hypno-CBT (HCBT), all of which are very popular.

Factors outside a psychiatrist’s control

It is frustrating to be unable to fix the situation that my patients find themselves in – including economic problems and lack of employment. We passionately desire peace and equality – in treatments, opportunity and life.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Stai abbandonando il sito Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
ACCESSO RISERVATO A OPERATORI SANITARI AUTORIZZATI
Per accedere alla pagina si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi. La pagina per la quale sta richiedendo l'accesso ospita materiale formativo comunque attinente all'impiego di medicinali prodotti o commercializzati da Lundbeck. Con riferimento al Decreto Legislativo n.219 del 24 aprile 2006 e s.m.i., art. 119, art. 121 comma 1 e art. 124 commi 4 e 8, Lundbeck limita l'accesso ai contenuti presenti nella pagina PIM Academy a medici specialisti e farmacisti ospedalieri.
Ciao
Per favore, conferma la tua email
Ti abbiamo appena inviato un'e-mail con un link di conferma.
Prima di poter ottenere l'accesso completo, devi confermare la tua email.
Le informazioni su questo sito sono destinate esclusivamente ai professionisti della salute.
Congress
Register for access to Progress in Mind in your country